This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. (REGN) inched 0.02% higher to $647.06 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.95% to 4,395.64 and the Dow Jones Industrial Average rising 1.00% to 34,258.32. This was the stock's second consecutive day of gains. Regeneron Pharmaceuticals Inc. closed $39.56 short of its 52-week high ($686.62), which the company achieved on September 3rd.
The stock outperformed some of its competitors Wednesday, as Johnson & Johnson (JNJ) fell 0.36% to $163.93, Novartis AG ADR (NOVN.EB) fell 0.30% to $82.80, and Amgen Inc. (AMGN) fell 0.80% to $213.64. Trading volume (556,867) remained 167,268 below its 50-day average volume of 724,135.
Data source: Dow Jones Market Data, FactSet. Data compiled September 22, 2021.
-MarketWatch Automation